Joyce Houterman

Investment Manager

2 past transactions

Prolira

Venture Round in 2022
Prolira BV, based in Utrecht, the Netherlands, specializes in developing medical diagnostic devices for the early detection of delirium and acute encephalopathy. Founded in 2015 as a spin-off from the University Medical Center Utrecht, the company has created DeltaScan, an EEG-based device that includes a single-use electrode patch and a monitoring module. DeltaScan analyzes brain activity to provide healthcare professionals with critical insights for timely interventions. The device features a validated algorithm that enhances brain signal monitoring, displayed on a portable monitor. Prolira's management team leads various specialized groups focused on technical development, market introduction, and clinical evaluation, with support from an advisory board and collaborations with prominent academic medical centers across Europe. The company's innovation aims to improve patient outcomes by facilitating prompt diagnosis and treatment of brain-related conditions.

Prepr

Series A in 2022
Hi there, nice to meet you. We are Prepr, and we are the world’s first data-driven headless content management system. With just one solution, we offer you all the tools you need to publish impactful content.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.